Lipid Nanocarriers: Promising Approach for Ora Drug Delivery System

被引:2
作者
Yadav, Vinod Kumar [1 ]
Gowda, Devegowda Vishakante [1 ]
Veeranna, Balamuralidhara [1 ]
机构
[1] JSS Coll Pharm, Dept Pharmaceut, Mysuru 570015, Karnataka, India
关键词
Lymphatic system; Liposome; Solid lipid nanoparticle; Self-nanoemulsifying; Nanostructural lipid carrier;
D O I
10.5530/ijper.54.2s.59
中图分类号
G40 [教育学];
学科分类号
040101 ; 120403 ;
摘要
Background: A suitable drug delivery system has been work on the strategy to enable safe and effective therapeutic efficacy. Drug discovery program, it has huge number of drug molecules are lipophilic as poor aqueous soluble. Oral drug delivery system is a safe, convenient and easy route for drug administration. Bioavailability is a major issue. Drug administrated with low bioavailability may lead to an ineffective therapeutic efficacy and several adverse effects. However, there are several reasons which may be responsible for poor bioavailability such as constraints of aqueous solubility, poor dissolution rate and permeability, hepatic first-pass metabolism and efflux. These hindrances are the massive challenges of poorly aqueous soluble drugs. Although, conventional approaches have troubles to succeed efficacious therapeutic efficacy of drug. Materials and Methods: Lipid nanocarriers have been promising and attractive approach and widely used in formulation development to improve the therapeutic efficacy of drugs. These nanocarriers have made the drug in pre-dissolved form with high durability Results: Lipid nanocarriers are more biodegradable, safe and bio-friendly with the biological system. Lipid nanocarriers have potentially overcome such hindrances thus improve the therapeutic efficacy to the drugs. Recently, lipid nanocarriers including it generations have widely preferred in formulation development due to its high durability and uniformity. Conclusion: Therefore, lipid nanocarriers have been considered as safe, prominent and robust strategy for improving the therapeutic efficacy of poorly aqueous soluble drugs.
引用
收藏
页码:S32 / S42
页数:11
相关论文
共 50 条
  • [41] Construction of WS2/Au-lipid drug delivery system for multiple combined therapy of tumor
    Li, Jiaqian
    Qi, Xiating
    Ye, Pengkun
    Yang, Mei
    Xie, Meng
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 76
  • [42] Panobinostat-loaded folate targeted liposomes as a promising drug delivery system for treatment of canine B-cell lymphoma
    Andre, Ana S.
    Dias, Joana N. R.
    Aguiar, Sandra I.
    Leonardo, Ana
    Nogueira, Sara
    Amaral, Joana D.
    Fernandes, Celia
    Gano, Lurdes
    Correia, Joao D. G.
    Cavaco, Marco
    Neves, Vera
    Correia, Jorge
    Castanho, Miguel
    Rodrigues, Cecilia M. P.
    Gaspar, Maria Manuela
    Tavares, Luis
    Aires-da-Silva, Frederico
    FRONTIERS IN VETERINARY SCIENCE, 2023, 10
  • [43] Supramolecular assemblies for improved drug delivery system
    Sunamoto, J
    ADVANCED BIOMATERIALS IN BIOMEDICAL ENGINEERING AND DRUG DELIVERY SYSTEMS, 1996, : 76 - 80
  • [44] Targeting Modification of Liposome Drug Delivery System
    Du, Sang
    Cui, Shao-Hui
    Chen, Xing-Yan
    Zhang, Shu-Biao
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2023, 50 (06) : 1272 - 1285
  • [45] Lipid-Based Drug Delivery System (LBDDS): An Emerging Paradigm to Enhance Oral Bioavailability of Poorly Soluble Drugs
    Roohi Kesharwani
    Pankaj Jaiswal
    Dilip Kumar Patel
    Pankaj Kumar Yadav
    Biomedical Materials & Devices, 2023, 1 (2): : 648 - 663
  • [46] Cisplatin-based Liposomal Nanocarriers for Drug Delivery in Lung Cancer Therapy: Recent Progress and Future Outlooks
    Mohammad-Jafari, Kave
    Naghib, Seyed Morteza
    Mozafari, M. R.
    CURRENT PHARMACEUTICAL DESIGN, 2024, 30 (36) : 2850 - 2881
  • [47] Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization
    E. Rostami
    S. Kashanian
    A. H. Azandaryani
    Molecular Biology Reports, 2014, 41 : 3521 - 3527
  • [48] Preparation of solid lipid nanoparticles as drug carriers for levothyroxine sodium with in vitro drug delivery kinetic characterization
    Rostami, E.
    Kashanian, S.
    Azandaryani, A. H.
    MOLECULAR BIOLOGY REPORTS, 2014, 41 (05) : 3521 - 3527
  • [49] Development of terbinafine solid lipid nanoparticles as a topical delivery system
    Chen, Ying-Chen
    Liu, Der-Zen
    Liu, Jun-Jen
    Chang, Tsung-Wei
    Ho, Hsiu-O
    Sheu, Ming-Thau
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 4409 - 4418
  • [50] Development and Evaluation of Lipid Nanoparticles for Drug Delivery: Study of Toxicity In Vitro and In Vivo
    Winter, Evelyn
    Dal Pizzol, Carine
    Locatelli, Claudriana
    Crezkynski-Pasa, Tania Beatriz
    JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY, 2016, 16 (02) : 1321 - 1330